| [1] |
.
[J]. Clinical Focus, 2024, 39(2): 177-182.
|
| [2] |
.
[J]. Clinical Focus, 2024, 39(1): 84-87.
|
| [3] |
.
[J]. Clinical Focus, 2023, 38(10): 935-939.
|
| [4] |
.
[J]. Clinical Focus, 2023, 38(6): 559-563.
|
| [5] |
Zhang Yuan, Zhou Juan, Li Wenxiang, Liu Jinxiang, Tang Xiaomei, Luo Huijuan.
Correlation between pruritus and the prognosis of intrahepatic cholestasis of pregnancy and prediction of its risks
[J]. Clinical Focus, 2023, 38(5): 405-411.
|
| [6] |
.
[J]. Clinical Focus, 2023, 38(4): 373-376.
|
| [7] |
Cao Yumeng, Zhang Haiyan, Liu Lixin.
Correlation between pathological changes and serum ferritin and iron levels in nonalcoholic fatty liver disease: A meta-analysis
[J]. Clinical Focus, 2023, 38(3): 197-207.
|
| [8] |
.
[J]. Clinical Focus, 2022, 37(9): 846-854.
|
| [9] |
Zhang Limin, Sun Jun.
Predictive value of FIB-4 in patients with metabolic-associated fatty liver disease complicated with colorectal adenomatous polyps
[J]. Clinical Focus, 2022, 37(4): 334-338.
|
| [10] |
Wang Dandan, Zhang Xiaolan, Deng Zhihua.
Clinical characteristic of Primary biliary cholangitis complicating Sjögren syndrome
[J]. Clinical Focus, 2022, 37(1): 30-34.
|
| [11] |
Wen Jie.
Correlation analysis between atherogenic index of plasma and nonalcoholic fatty liver disease
[J]. Clinical Focus, 2022, 37(1): 35-38.
|
| [12] |
Qu Ying, Liu Zhongyang.
Relationship between tuberculin test with serum apolipoprotein A-1 and anti-tuberculosis drug-induced liver injury
[J]. Clinical Focus, 2022, 37(1): 39-42.
|
| [13] |
.
[J]. Clinical Focus, 2022, 37(1): 72-76.
|
| [14] |
Yang Zhibin, Shao Yanfang, Pan Li, Yang Yanxia, Yang Yuxi, Zhao Lihui, Zeng Rongkun, Li Yang, Wang Qiaofeng, Wang Cong, Ma Shiwu.
Efficacy of magnesium isoglycyrrhizinate in anti-tuberculosis drug-induced liver injury
[J]. Clinical Focus, 2021, 36(11): 972-975.
|
| [15] |
.
[J]. Clinical Focus, 2021, 36(9): 856-860.
|
